The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
President Donald Trump's administration has disbanded an FBI task force focused on investigating foreign influence campaigns ...
A lawyer leading a class action lawsuit says Kiwis may have spent a significant amount on ineffective medicines.
USF “recently” added Narcan, an emergency medication that reverses an opioid overdose, to its residence halls, complying with a year-old regulation. Narcan is formally known as Naloxone. The nasal ...
Phenylephrine is a commonly used ingredient in cold and flu medications as a nasal and sinus decongestant. It is present in several on-the-shelf cold and flu medications in New Zealand, including ...
A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...
Spravato is a ketamine-derived nasal spray that is FDA-approved for treatment-resistant depression. The Johnson & Johnson drug has been on the market since 2019, but could only be prescribed ...
An estimated 21 million American adults suffer from clinical depression. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.